geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Tests with human volunteers on parenteral utilization of maltose


, : Tests with human volunteers on parenteral utilization of maltose. Zeitschrift für Ernahrungswissenschaft 15(3): 284-293

Intravenous infusions of maltose were performed using human volunteers. Four volunteers received maltose in a dose of 0.25 g/kg bodyweight and hour during eight hours. A follow-up period of three hours was added. Six volunteers received maltose in a dose of 0.125 g/kg bodyweight and hour during twelve hours. Only with the lower dose of maltose (0.125 g/kg b.w.) a steady state is reached after six hour continuous infusion. However even under these conditions maltose concentration in blood reaches the high concentration of 70 mg/100 ml. Using the double infusion rate, no steady state is attained when the infusions lasted for eight hours, despite maltose concentration in blood measured 150 mg/100 ml at this time. By measuring different metabolic parameters (fatty acid concentration, phosphate concentration) it is shown that parenterally applicated maltose is metabolized in the human. On the other hand, adverse reactions were not observed. The concentrations of uric acid and bilirubin remain constant and the activity of SGOT is not altered. Renal excretion of sugar measures 25-35% of the maltose administered parenterally. It is concluded that the glucose in urine stems from direct intra tubular hydrolysis of maltose achieved by the neutral maltase of the kidneys. The lack of attaining constant blood concentration for maltose during the infusions and the high renal loss of sugar shows that maltose is not suited as the single substrate for parenteral nutrition. However, there remains the possibility to use maltose in combination with glucose substitutes. The metabolic behaviour of maltose is similar to glucose, it differs from glucose substitutes.

US$29.90

PMID: 969714


Other references

Salcedo, J., 1953: Philippine medicine in the last fifty years. Journal of the Philippine Medical Association 29(10): 535-537

Anonymous, 1969: Annual report of the Fission Product Inhalation Program Lovelace Foundation for medical education and research, Albuquerque, New Mexico 87108. September 1968 through September 1969. LF-41. Fission Product Inhalation Project Technical Progress Report . Lovelace Foundation for Medical Education and Research: 1-249

Main C.E.; Chaplin J.F., 1972: Brown spot damage and flue cured tobacco d quality part 3 alterations in physical characteristics and color of cured leaf in relation to disease severity. Tobacco Science 16: 26-31

Siriwardena, A.Niroshan., 2008: Creating a quality healthcare system for the 21st century. Quality in Primary Care 16(5): 305-307

Hallman, M.; Slivka, S.; Bry, K., 1994: Surfactant administered to amniotic fluid enters the lungs via airway epithelium. Pediatric Research 35(4 PART 2): 336A

George, E.P., 1948: Origin of cosmic ray stars. Nature 162(4113): 333-333

Muñoz Sanz, A., 1997: It's time to join efforts in favor of the accreditation in infectious diseases. Medicina Clinica 109(3): 115-115

James, E.Caple., 2010: Ruptures, rights, and repair: the political economy of trauma in Haiti. This article analyzes the unintended consequences of humanitarian and development interventions in Haiti implemented to facilitate its postconflict transition following the period of military rule between 1991 and 1994. International and national...

Over, H.H.; Tözün, N.; Avşar, E., 1998: Toothpick impaction: treatment by colonoscopy. Endoscopy 29(9): S60-S61

Van Snick, G.; Camerlijnck, 1966: The Pietrain pig. A review, including the origin of the breed, breeding performance and mothering ability, growth rate, and carcass characters.